Egenskap
Arthritis
Inflammation of a joint.
Sammendrag
- Også kalt
- Joint inflammation
- Kroppssystem
- Abnormality of the musculoskeletal system
ReferansegenomGRCh38hg38
Posisjoner på gen- og variantsidene følger dette valget i denne nettleseren.
Read the genes linked to Arthritis, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test173 gener knyttet til Arthritis
Endringer i disse genene forårsaker sjeldne tilstander der Arthritis forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| ELF4E74 like ETS transcription factor 4 | Alltid | I 1 tilstand |
| IKZF2IKAROS family zinc finger 2 | Alltid | I 1 tilstand |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Alltid | I 1 tilstand |
| NLRP3NLR family pyrin domain containing 3 | Alltid | I 5 tilstander |
| PDCD1programmed cell death 1 | Alltid | I 2 tilstander |
| PLD4phospholipase D family member 4 | Alltid | I 1 tilstand |
| PSTPIP1proline-serine-threonine phosphatase interacting protein 1 | Alltid | I 2 tilstander |
| TBK1TANK binding kinase 1 | Alltid | I 1 tilstand |
| TRAF3TNF receptor associated factor 3 | Alltid | I 1 tilstand |
| ANKHANKH inorganic pyrophosphate transport regulator | Svært ofte (80–99 %) | I 1 tilstand |
| ANKRD55ankyrin repeat domain 55 | Svært ofte (80–99 %) | I 2 tilstander |
| ASAH1N-acylsphingosine amidohydrolase 1 | Svært ofte (80–99 %) | I 2 tilstander |
| ATP7BATPase copper transporting beta | Svært ofte (80–99 %) | I 1 tilstand |
| C4Acomplement C4A (Chido/Rodgers blood group) | Svært ofte (80–99 %) | I 2 tilstander |
| CCR1C-C motif chemokine receptor 1 | Svært ofte (80–99 %) | I 1 tilstand |
| CD247CD247 molecule | Svært ofte (80–99 %) | I 2 tilstander |
| CD4CD4 molecule | Svært ofte (80–99 %) | I 1 tilstand |
| CLCN7Cl-/H+ antiporter 7 | Svært ofte (80–99 %) | I 1 tilstand |
| COPAcoat protein complex I subunit alpha | Svært ofte (80–99 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| FASFas cell surface death receptor | Svært ofte (80–99 %) | I 2 tilstander |
| GLAgalactosidase alpha | Svært ofte (80–99 %) | I 1 tilstand |
| HGDhomogentisate 1,2-dioxygenase | Svært ofte (80–99 %) | I 2 tilstander |
| HLA-Bmajor histocompatibility complex, class I, B | Svært ofte (80–99 %) | I 4 tilstander |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Svært ofte (80–99 %) | I 6 tilstander |
| IFNGR1interferon gamma receptor 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IL10interleukin 10 | Svært ofte (80–99 %) | I 2 tilstander |
| IL12Ainterleukin 12A | Svært ofte (80–99 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Svært ofte (80–99 %) | I 1 tilstand |
| IL2RAinterleukin 2 receptor subunit alpha | Svært ofte (80–99 %) | I 2 tilstander |
| IL2RBinterleukin 2 receptor subunit beta | Svært ofte (80–99 %) | I 2 tilstander |
| IL6interleukin 6 | Svært ofte (80–99 %) | I 1 tilstand |
| IRF4interferon regulatory factor 4 | Svært ofte (80–99 %) | I 2 tilstander |
| KLRC4killer cell lectin like receptor C4 | Svært ofte (80–99 %) | I 1 tilstand |
| LACC1laccase domain multifunctional purine nucleosidase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Svært ofte (80–99 %) | I 3 tilstander |
| MIFmacrophage migration inhibitory factor | Svært ofte (80–99 %) | I 1 tilstand |
| MMP14matrix metallopeptidase 14 | Svært ofte (80–99 %) | I 1 tilstand |
| MMP2matrix metallopeptidase 2 | Svært ofte (80–99 %) | I 1 tilstand |
Vis 133 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| NOD2nucleotide binding oligomerization domain containing 2 | Svært ofte (80–99 %) | I 3 tilstander |
| PTPN2protein tyrosine phosphatase non-receptor type 2 | Svært ofte (80–99 %) | I 2 tilstander |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Svært ofte (80–99 %) | I 5 tilstander |
| STAT4signal transducer and activator of transcription 4 | Svært ofte (80–99 %) | I 5 tilstander |
| TLR4toll like receptor 4 | Svært ofte (80–99 %) | I 1 tilstand |
| TNFRSF11BTNF receptor superfamily member 11b | Svært ofte (80–99 %) | I 1 tilstand |
| UBAC2UBA domain containing 2 | Svært ofte (80–99 %) | I 1 tilstand |
| AP1S3adaptor related protein complex 1 subunit sigma 3 | Ofte (30–79 %) | I 1 tilstand |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Ofte (30–79 %) | I 1 tilstand |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| BLNKB cell linker | Ofte (30–79 %) | I 1 tilstand |
| BTKBruton tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| C1QBcomplement C1q B chain | Ofte (30–79 %) | I 1 tilstand |
| C2orf69chromosome 2 open reading frame 69 | Ofte (30–79 %) | I 1 tilstand |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Ofte (30–79 %) | I 1 tilstand |
| CAV1caveolin 1 | Ofte (30–79 %) | I 1 tilstand |
| CCN2cellular communication network factor 2 | Ofte (30–79 %) | I 1 tilstand |
| CCR6C-C motif chemokine receptor 6 | Ofte (30–79 %) | I 1 tilstand |
| CD79ACD79a molecule | Ofte (30–79 %) | I 1 tilstand |
| CD79BCD79b molecule | Ofte (30–79 %) | I 1 tilstand |
| COL2A1collagen type II alpha 1 chain | Ofte (30–79 %) | I 1 tilstand |
| CR2complement C3d receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Ofte (30–79 %) | I 3 tilstander |
| DNASE1deoxyribonuclease 1 | Ofte (30–79 %) | I 2 tilstander |
| DNASE1L3deoxyribonuclease 1L3 | Ofte (30–79 %) | I 1 tilstand |
| ETS1ETS proto-oncogene 1, transcription factor | Ofte (30–79 %) | I 1 tilstand |
| FCGR2BFc gamma receptor IIb | Ofte (30–79 %) | I 2 tilstander |
| FCGR3BFc gamma receptor IIIb | Ofte (30–79 %) | I 1 tilstand |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Ofte (30–79 %) | I 1 tilstand |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Ofte (30–79 %) | I 1 tilstand |
| HPGD15-hydroxyprostaglandin dehydrogenase | Ofte (30–79 %) | I 3 tilstander |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Ofte (30–79 %) | I 1 tilstand |
| IGHMimmunoglobulin heavy constant mu | Ofte (30–79 %) | I 1 tilstand |
| IGLL1immunoglobulin lambda like polypeptide 1 | Ofte (30–79 %) | I 1 tilstand |
| IL12Binterleukin 12B | Ofte (30–79 %) | I 1 tilstand |
| IL36RNinterleukin 36 receptor antagonist | Ofte (30–79 %) | I 1 tilstand |
| IRAK1interleukin 1 receptor associated kinase 1 | Ofte (30–79 %) | I 2 tilstander |
| IRF5interferon regulatory factor 5 | Ofte (30–79 %) | I 2 tilstander |
| ITGAMintegrin subunit alpha M | Ofte (30–79 %) | I 1 tilstand |
| JAZF1JAZF zinc finger 1 | Ofte (30–79 %) | I 1 tilstand |
| KIAA0319LKIAA0319 like | Ofte (30–79 %) | I 1 tilstand |
| KNSTRNkinetochore localized astrin (SPAG5) binding protein | Ofte (30–79 %) | I 2 tilstander |
| LBRlamin B receptor | Ofte (30–79 %) | I 1 tilstand |
| LMX1BLIM homeobox transcription factor 1 beta | Ofte (30–79 %) | I 1 tilstand |
| LRRC8Aleucine rich repeat containing 8 VRAC subunit A | Ofte (30–79 %) | I 1 tilstand |
| MECP2methyl-CpG binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| MLXMAX dimerization protein MLX | Ofte (30–79 %) | I 1 tilstand |
| MVKmevalonate kinase | Ofte (30–79 %) | I 2 tilstander |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Ofte (30–79 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Ofte (30–79 %) | I 1 tilstand |
| PIK3CDphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | Ofte (30–79 %) | I 3 tilstander |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| PRKCDprotein kinase C delta | Ofte (30–79 %) | I 1 tilstand |
| PRPS1phosphoribosyl pyrophosphate synthetase 1 | Ofte (30–79 %) | I 2 tilstander |
| PRTN3proteinase 3 | Ofte (30–79 %) | I 1 tilstand |
| PXKPX domain containing serine/threonine kinase like | Ofte (30–79 %) | I 1 tilstand |
| SHARPINSHANK associated RH domain interactor | Ofte (30–79 %) | I 1 tilstand |
| SLCO2A1solute carrier organic anion transporter family member 2A1 | Ofte (30–79 %) | I 1 tilstand |
| SPI1Spi-1 proto-oncogene | Ofte (30–79 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Ofte (30–79 %) | I 2 tilstander |
| TCF3transcription factor 3 | Ofte (30–79 %) | I 1 tilstand |
| TLR7toll like receptor 7 | Ofte (30–79 %) | I 1 tilstand |
| TNFAIP3TNF alpha induced protein 3 | Ofte (30–79 %) | I 1 tilstand |
| TNFRSF1ATNF receptor superfamily member 1A | Ofte (30–79 %) | I 1 tilstand |
| TNFSF4TNF superfamily member 4 | Ofte (30–79 %) | I 1 tilstand |
| TNIP1TNFAIP3 interacting protein 1 | Ofte (30–79 %) | I 1 tilstand |
| TREX1three prime repair exonuclease 1 | Ofte (30–79 %) | I 3 tilstander |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Ofte (30–79 %) | I 1 tilstand |
| ACP5acid phosphatase 5, tartrate resistant | Noen ganger (5–29 %) | I 1 tilstand |
| ADARadenosine deaminase RNA specific | Noen ganger (5–29 %) | I 1 tilstand |
| AGAaspartylglucosaminidase | Noen ganger (5–29 %) | I 1 tilstand |
| ARVCFARVCF delta catenin family member | Noen ganger (5–29 %) | I 1 tilstand |
| BMP6bone morphogenetic protein 6 | Noen ganger (5–29 %) | I 1 tilstand |
| BTNL2butyrophilin like 2 | Noen ganger (5–29 %) | I 1 tilstand |
| COMTcatechol-O-methyltransferase | Noen ganger (5–29 %) | I 1 tilstand |
| EPCAMepithelial cell adhesion molecule | Noen ganger (5–29 %) | I 2 tilstander |
| EXT1exostosin glycosyltransferase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| EXT2exostosin glycosyltransferase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| FOXP3forkhead box P3 | Noen ganger (5–29 %) | I 1 tilstand |
| GJB2gap junction protein beta 2 | Noen ganger (5–29 %) | I 1 tilstand |
| GJB6gap junction protein beta 6 | Noen ganger (5–29 %) | I 1 tilstand |
| GP1BBglycoprotein Ib platelet subunit beta | Noen ganger (5–29 %) | I 1 tilstand |
| HFEhomeostatic iron regulator | Noen ganger (5–29 %) | I 1 tilstand |
| HIRAhistone cell cycle regulator | Noen ganger (5–29 %) | I 1 tilstand |
| HNF1BHNF1 homeobox B | Noen ganger (5–29 %) | I 1 tilstand |
| IFIH1interferon induced with helicase C domain 1 | Noen ganger (5–29 %) | I 2 tilstander |
| IGHG2immunoglobulin heavy constant gamma 2 (G2m marker) | Noen ganger (5–29 %) | I 1 tilstand |
| IGKCimmunoglobulin kappa constant | Noen ganger (5–29 %) | I 1 tilstand |
| JMJD1Cjumonji domain containing 1C | Noen ganger (5–29 %) | I 1 tilstand |
| LRBALPS responsive beige-like anchor protein | Noen ganger (5–29 %) | I 1 tilstand |
| LSM11LSM11, U7 small nuclear RNA associated | Noen ganger (5–29 %) | I 1 tilstand |
| PHEXphosphate regulating endopeptidase X-linked | Noen ganger (5–29 %) | I 1 tilstand |
| RNASEH2Aribonuclease H2 subunit A | Noen ganger (5–29 %) | I 1 tilstand |
| RNASEH2Bribonuclease H2 subunit B | Noen ganger (5–29 %) | I 1 tilstand |
| RNASEH2Cribonuclease H2 subunit C | Noen ganger (5–29 %) | I 1 tilstand |
| RNF168ring finger protein 168 | Noen ganger (5–29 %) | I 1 tilstand |
| RNU7-1RNA, U7 small nuclear 1 | Noen ganger (5–29 %) | I 1 tilstand |
| RREB1ras responsive element binding protein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SAMHD1SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SEC24CSEC24 homolog C, COPII component | Noen ganger (5–29 %) | I 1 tilstand |
| SYKspleen associated tyrosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| TBX1T-box transcription factor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| TFtransferrin | Noen ganger (5–29 %) | I 1 tilstand |
| THSD4thrombospondin type 1 domain containing 4 | Noen ganger (5–29 %) | I 1 tilstand |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Noen ganger (5–29 %) | I 1 tilstand |
| VPS13Avacuolar protein sorting 13 homolog A | Noen ganger (5–29 %) | I 1 tilstand |
| WASWASP actin nucleation promoting factor | Noen ganger (5–29 %) | I 1 tilstand |
| XIAPX-linked inhibitor of apoptosis | Noen ganger (5–29 %) | I 1 tilstand |
| CASP10caspase 10 | Sjelden (1–4%) | I 1 tilstand |
| FASLGFas ligand | Sjelden (1–4%) | I 1 tilstand |
| FGF10fibroblast growth factor 10 | Sjelden (1–4%) | I 1 tilstand |
| FGFR2fibroblast growth factor receptor 2 | Sjelden (1–4%) | I 1 tilstand |
| FGFR3fibroblast growth factor receptor 3 | Sjelden (1–4%) | I 1 tilstand |
| KRT5keratin 5 | Sjelden (1–4%) | I 1 tilstand |
| MYH14myosin heavy chain 14 | Sjelden (1–4%) | I 1 tilstand |
| POFUT1protein O-fucosyltransferase 1 | Sjelden (1–4%) | I 1 tilstand |
| POGLUT1protein O-glucosyltransferase 1 | Sjelden (1–4%) | I 1 tilstand |
| PSENENpresenilin enhancer, gamma-secretase subunit | Sjelden (1–4%) | I 1 tilstand |
| ABCG2ATP binding cassette subfamily G member 2 (JR blood group) | Ikke registrert | I 1 tilstand |
| ABCG8ATP binding cassette subfamily G member 8 | Ikke registrert | I 1 tilstand |
| ADA2adenosine deaminase 2 | Ikke registrert | I 1 tilstand |
| FCGR2AFc gamma receptor IIa | Ikke registrert | I 1 tilstand |
| HJVhemojuvelin BMP co-receptor | Ikke registrert | I 1 tilstand |
| HLA-Cmajor histocompatibility complex, class I, C | Ikke registrert | I 1 tilstand |
| HOXD10homeobox D10 | Ikke registrert | I 1 tilstand |
| NLRP12NLR family pyrin domain containing 12 | Ikke registrert | I 1 tilstand |
| PRG4proteoglycan 4 | Ikke registrert | I 1 tilstand |
| PSMB4proteasome 20S subunit beta 4 | Ikke registrert | I 1 tilstand |
| RAG1recombination activating 1 | Ikke registrert | I 1 tilstand |
| RAG2recombination activating 2 | Ikke registrert | I 1 tilstand |
| TFR2transferrin receptor 2 | Ikke registrert | I 1 tilstand |
| UBA1ubiquitin like modifier activating enzyme 1 | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Smalere egenskaper
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker